Product Description: Avizakimab (BOS161721) is a humanized IgG1 monoclonal antibody that targets interleukin-21[1].
Applications: COVID-19-immunoregulation
Formula: N/A
References: [1]Hussaini A, et al. A Double-Blind, Phase I, Single Ascending Dose Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of BOS161721 in Healthy Subjects. Clin Transl Sci. 2020 Mar;13(2):337-344.
CAS Number: 2229685-51-0
Molecular Weight: N/A
Compound Purity: 99.35
Research Area: Inflammation/Immunology
Solubility: H2O
Target: Interleukin Related